ArticleJID innovations : skin science from molecules to population health2024

ATI-1777, a Topical Jak1/3 Inhibitor, May Benefit Atopic Dermatitis without Systemic Drug Exposure: Results from Preclinical Development and Phase 2a Randomized Control Study ATI-1777-AD-201.

Paul Changelian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.